| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Immutep Limited (AU: IMM)
IMM Technical Analysis
5
| As on 13th Mar 2026 IMM STOCK Price closed @ 0.04 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.28 & Strong Sell for SHORT-TERM with Stoploss of 0.33 we also expect STOCK to react on Following IMPORTANT LEVELS. |
IMMSTOCK Price
| Open | 0.03 | Change | Price | % |
| High | 0.05 | 1 Day | -0.36 | -90.00 |
| Low | 0.03 | 1 Week | -0.36 | -90.00 |
| Close | 0.04 | 1 Month | -0.42 | -91.30 |
| Volume | 432932084 | 1 Year | -0.28 | -87.50 |
| 52 Week High 0.46 | 52 Week Low 0.04 | ||||
AU Australia Most Active Stocks
| IMM | 0.04 | -90.00% |
| RML | 0.06 | 20.00% |
| SGQ | 0.14 | 0.00% |
| SYR | 0.17 | -29.17% |
| AGR | 0.02 | 0.00% |
| EQR | 0.36 | 5.88% |
| AGE | 0.05 | 25.00% |
| NES | 0.00 | % |
| TER | 0.10 | 0.00% |
| LSR | 0.02 | 0.00% |
AU Australia Top Gainers Stocks
AU Australia Top Losers Stocks
| IMM Daily Charts |
IMM Intraday Charts |
Whats New @ Bazaartrend |
IMM Free Analysis |
|
|
IMM Important Levels Intraday
| RESISTANCE | 0.08 |
| RESISTANCE | 0.07 |
| RESISTANCE | 0.06 |
| RESISTANCE | 0.05 |
| SUPPORT | 0.03 |
| SUPPORT | 0.02 |
| SUPPORT | 0.01 |
| SUPPORT | 0.00 |
IMM Forecast March 2026
| 4th UP Forecast | 0.14 |
| 3rd UP Forecast | 0.11 |
| 2nd UP Forecast | 0.09 |
| 1st UP Forecast | 0.07 |
| 1st DOWN Forecast | 0.01 |
| 2nd DOWN Forecast | -0.01 |
| 3rd DOWN Forecast | -0.03 |
| 4th DOWN Forecast | -0.06 |
IMM Weekly Forecast
| 4th UP Forecast | 0.17 |
| 3rd UP Forecast | 0.13 |
| 2nd UP Forecast | 0.10 |
| 1st UP Forecast | 0.08 |
| 1st DOWN Forecast | 0.00 |
| 2nd DOWN Forecast | -0.02 |
| 3rd DOWN Forecast | -0.05 |
| 4th DOWN Forecast | -0.09 |
IMM Forecast2026
| 4th UP Forecast | 0.89 |
| 3rd UP Forecast | 0.62 |
| 2nd UP Forecast | 0.45 |
| 1st UP Forecast | 0.28 |
| 1st DOWN Forecast | -0.2 |
| 2nd DOWN Forecast | -0.37 |
| 3rd DOWN Forecast | -0.54 |
| 4th DOWN Forecast | -0.81 |
Immutep Limited ( AU Australia Symbol : IMM )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
IMM Business Profile
Immutep Limited, a biotech company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its principal product candidate is IMP321, also known as ?eftilagimod alpha' or ?efti', which is a recombinant protein that is in Phase IIb clinical trial as a chemoimmunotherapy combination for metastatic breast cancer termed AIPAC; and is being evaluated as a combination therapy in head and neck squamous cell carcinoma and non-small cell lung carcinoma in a Phase II clinical trial called TACTI-002 and an investigator initiated Phase I trial called INSIGHT in advanced solid tumors. Its other products include IMP761, IMP701 and IMP731, all of which are related to lymphocyte activation gene 3, a gene linked to the regulation of T cells in immune responses. It has partnerships with GlaxoSmithKline, Novartis, CYTLIMIC Inc., INSIGHT, and EOC Pharma. The company was formerly known as Prima BioMed Ltd and changed its name to Immutep Limited in November 2017. Immutep Limited was incorporated in 1987 and is based in Sydney, Australia. Address: 95 Pitt Street, Sydney, NSW, Australia, 2000
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service